Log in
Create new account
home
boards
job center
archives
company monitor
cp wire
device news
pharmagather
advertise
contact us
Home
exenatide
Blockbuster Breakup: Amylin Buys Out Lilly's Exenatide Rights
Blockbuster Breakup: Amylin Buys Out Lilly's Exenatide Rights
Motley Fool
Amylin
diabetes
Eli Lilly
exenatide
Exenatide tQT Study Showed No Prolongation of QT Interval
Exenatide tQT Study Showed No Prolongation of QT Interval
Pipeline Review
Alkermes
Amylin
Bydureon
Byetta
diabetes
Eli Lilly
exenatide
News
Amylin Braces for Big Event of 2010, the (Hoped-For) Approval of Once-Weekly Diabetes Drug
Xconomy
Amylin
diabetes
Eli Lilly
exenatide
»
115 comments
News
Amylin Gets Positive Results
Yahoo/Zacks.com
Alkermes
Amylin
AstraZeneca
Eli Lilly
exenatide
Lantus
Sanofi
»
Login
or
register
to post comments
News
Lilly, Amylin sign exenatide deal
Bizjournals.com
Amylin
Eli Lilly
exenatide
partnerships
»
111 comments
News
Lazard sees Amylin's exenatide as a blockbuster
Yahoo/AP
Amylin
Byetta
diabetes
Eli Lilly
exenatide
»
Login
or
register
to post comments
news tags
Abbott Laboratories
Amgen
Arena Pharmaceuticals
AstraZeneca
Bayer
Biogen Idec
biotech
Boston Scientific
Bristol-Myers Squibb
cancer
Celgene
China
Dendreon
diabetes
earnings
Eli Lilly
Europe
FDA
generics
Genzyme
GSK
hepatitis C
investors
JNJ
lawsuits
layoffs
M&A
Management
Medtronic
Merck
Novartis
obesity
patents
Pfizer
prostate cancer
Roche
Sanofi
Teva Pharmaceuticals
vaccines
Vivus
more tags
Yahoo! Finance
Quote for ABT